DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,565 filers reported holding DANAHER CORPORATION in Q2 2020. The put-call ratio across all filers is 1.06 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $56,690,850 | +5.5% | 228,500 | +2.0% | 1.64% | +10.4% |
Q2 2023 | $53,760,000 | +121.0% | 224,000 | +132.1% | 1.49% | +88.4% |
Q1 2023 | $24,321,860 | +1662.2% | 96,500 | +1755.8% | 0.79% | +1545.8% |
Q4 2022 | $1,380,184 | -90.5% | 5,200 | -90.7% | 0.05% | -85.8% |
Q3 2022 | $14,464,000 | -27.3% | 56,000 | -28.7% | 0.34% | -21.6% |
Q2 2022 | $19,901,000 | -38.7% | 78,500 | -29.0% | 0.43% | -18.6% |
Q1 2022 | $32,442,000 | +55.3% | 110,600 | +74.2% | 0.53% | +50.4% |
Q4 2021 | $20,892,000 | -56.7% | 63,500 | -59.9% | 0.35% | -56.7% |
Q3 2021 | $48,254,000 | -40.7% | 158,500 | -47.7% | 0.81% | -44.8% |
Q2 2021 | $81,313,000 | +75.4% | 303,000 | +47.1% | 1.47% | +63.8% |
Q1 2021 | $46,366,000 | -30.0% | 206,000 | -30.9% | 0.90% | -42.2% |
Q4 2020 | $66,198,000 | +52.2% | 298,000 | +47.5% | 1.55% | +38.4% |
Q3 2020 | $43,497,000 | +104.1% | 202,000 | +67.6% | 1.12% | +35.1% |
Q2 2020 | $21,308,000 | +32.7% | 120,500 | +3.9% | 0.83% | -34.0% |
Q1 2020 | $16,056,000 | +4.6% | 116,000 | +16.0% | 1.26% | -14.4% |
Q4 2019 | $15,348,000 | +252.1% | 100,000 | +227.9% | 1.47% | +217.3% |
Q2 2019 | $4,359,000 | -52.1% | 30,500 | -55.8% | 0.46% | -58.7% |
Q1 2019 | $9,109,000 | – | 69,000 | – | 1.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
Third Point | 2,450,000 | $607,845,000 | 9.22% |
Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |